INIS
administration
7%
angiotensin
100%
cavities
7%
cedars
28%
chains
28%
comparative evaluations
7%
control
14%
coronaviruses
100%
diseases
21%
enzymes
100%
fatty acids
28%
genes
7%
in vivo
7%
inflammation
14%
levels
14%
messenger-rna
7%
mucosa
100%
nose
100%
patients
35%
pollen
28%
polymerase chain reaction
7%
receptors
100%
regulations
100%
seasons
7%
tissues
14%
transmission
7%
viruses
7%
Medicine and Dentistry
Angiotensin Converting Enzyme 2
100%
Chronic Rhinosinusitis
28%
Development
7%
Endotype
7%
Epithelial Cell
35%
Gene Expression
7%
Infection
7%
Inpatient
7%
Messenger RNA
7%
Nasal Cavity
7%
Nasal Polyp
28%
Nasal Tissue
7%
Nose Mucosa
100%
Patient
28%
Pollen
28%
Pollen Allergy
21%
Real Time Polymerase Chain Reaction
7%
Receptor
100%
Regulatory Mechanism
100%
Serositis
7%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Short Chain Fatty Acid
28%
Subclinical Infection
7%
Tissues
7%
Upregulation
7%
Virus Receptor
7%
Immunology and Microbiology
Cells
83%
COVID-19
50%
Development
16%
Experiment
16%
Gene Expression
16%
Inflammation
16%
Intestine Flora
16%
Nasal Tissue
16%
Nose Mucosa
100%
Pollen
66%
Pollen Allergy
50%
Real Time Polymerase Chain Reaction
16%
Regulatory Mechanism
100%
Tissue Level
16%
Tissues
16%
Upregulation
16%
Virus
16%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Converting Enzyme 2
100%
Asymptomatic Infection
7%
Chronic Rhinosinusitis
28%
Coronavirinae
21%
Diseases
21%
Infection
7%
Inflammation
7%
Intestine Flora
7%
Japanese Cedar
28%
Messenger RNA
7%
Nose Polyp
28%
Pandemic
7%
Pollen
28%
Pollen Allergy
21%
Receptor
100%
SARS Coronavirus
100%
Short Chain Fatty Acid
28%
Virus Receptor
7%